Evidence map›Paper›PMID 37342694›Full record

ArticleBiomedical optics express2023

Central and peripheral refraction measured by a novel double-pass instrument.

Dimitrios Christaras, Spyridon Tsoukalas, Petros Papadogiannis, Charlie Börjeson, Moa Volny, Linda Lundström, Pablo Artal, Harilaos Ginis

Abstract read
In one paragraph

Article in Biomedical optics express, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Dynamic Tear Film Stability Assessed via an Open-View Double-Pass Imaging System.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2026
    Article
  3. Impact of Myopia Control Spectacles on Retinal Image Contrast.Investigative ophthalmology & visual science · 2026
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dimitrios ChristarasDiestia Systems, 77-79 Platonos str., 14401, Athens, Greece.
Spyridon TsoukalasDiestia Systems, 77-79 Platonos str., 14401, Athens, Greece.
Petros PapadogiannisDepartment of Applied Physics, Royal Institute of Technology, Stockholm, 11421, Sweden.ORCID https://orcid.org/0000-0003-0875-3325
Charlie BörjesonDepartment of Applied Physics, Royal Institute of Technology, Stockholm, 11421, Sweden.ORCID https://orcid.org/0000-0001-8837-3837
Moa VolnyDepartment of Applied Physics, Royal Institute of Technology, Stockholm, 11421, Sweden.
Linda LundströmDepartment of Applied Physics, Royal Institute of Technology, Stockholm, 11421, Sweden.ORCID https://orcid.org/0000-0002-4894-7944
Pablo ArtalLaboratorio de Optica, Universidad de Murcia, Campus de Espinardo (Edificio 34), E-30100 Murcia, Spain.ORCID https://orcid.org/0000-0003-1284-6591
Harilaos GinisDiestia Systems, 77-79 Platonos str., 14401, Athens, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel double-pass instrument and its data analysis method for the measurement of central and peripheral refraction is presented and validated in a group of healthy subjects. The instrument acquires in-vivo, non-cycloplegic, double-pass, through-focus images of the eye's central and peripheral point-spread function (PSF) using an infrared laser source, a tunable lens and a CMOS camera. The through-focus images were analyzed to determine defocus and astigmatism at 0° and 30° visual field. These values were compared to those obtained with a lab-based Hartmann-Shack wavefront sensor. The two instruments provided data showing good correlation at both eccentricities, particularly in the estimation of defocus.

Identifiers

PMID37342694
PMCPMC10278616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.